Kronos Bio Inc
NASDAQ:KRON
Income Statement
Earnings Waterfall
Kronos Bio Inc
Income Statement
Kronos Bio Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
19
|
31
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
3
+152%
|
4
+30%
|
6
+57%
|
8
+21%
|
8
+11%
|
10
+17%
|
10
0%
|
9
-7%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(26)
|
(43)
|
(58)
|
(77)
|
(97)
|
(110)
|
(151)
|
(162)
|
(166)
|
(166)
|
(137)
|
(130)
|
(128)
|
(127)
|
(123)
|
(115)
|
(104)
|
(90)
|
(73)
|
(60)
|
|
| Selling, General & Administrative |
(6)
|
(11)
|
(19)
|
(27)
|
(35)
|
(39)
|
(42)
|
(45)
|
(46)
|
(48)
|
(46)
|
(45)
|
(46)
|
(43)
|
(42)
|
(41)
|
(36)
|
(34)
|
(28)
|
(25)
|
|
| Research & Development |
(20)
|
(32)
|
(39)
|
(50)
|
(63)
|
(71)
|
(110)
|
(117)
|
(120)
|
(118)
|
(91)
|
(86)
|
(83)
|
(84)
|
(81)
|
(74)
|
(69)
|
(56)
|
(46)
|
(34)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(26)
N/A
|
(43)
-63%
|
(58)
-36%
|
(77)
-32%
|
(97)
-26%
|
(110)
-13%
|
(151)
-38%
|
(162)
-7%
|
(166)
-3%
|
(166)
+0%
|
(137)
+17%
|
(129)
+6%
|
(125)
+3%
|
(123)
+1%
|
(117)
+5%
|
(108)
+8%
|
(96)
+11%
|
(80)
+17%
|
(63)
+20%
|
(51)
+20%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
1
|
(18)
|
(30)
|
(31)
|
(31)
|
(12)
|
0
|
0
|
1
|
2
|
4
|
6
|
8
|
9
|
9
|
9
|
8
|
7
|
7
|
6
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(5)
|
(5)
|
(18)
|
(15)
|
(13)
|
(29)
|
(20)
|
|
| Pre-Tax Income |
(25)
N/A
|
(61)
-142%
|
(88)
-46%
|
(108)
-22%
|
(128)
-19%
|
(122)
+5%
|
(151)
-24%
|
(161)
-7%
|
(165)
-2%
|
(164)
+1%
|
(133)
+19%
|
(123)
+8%
|
(120)
+3%
|
(119)
+1%
|
(113)
+5%
|
(116)
-3%
|
(103)
+12%
|
(86)
+17%
|
(86)
-1%
|
(64)
+25%
|
|
| Net Income | |||||||||||||||||||||
| Income from Continuing Operations |
(25)
|
(61)
|
(88)
|
(108)
|
(128)
|
(122)
|
(151)
|
(161)
|
(165)
|
(164)
|
(133)
|
(123)
|
(120)
|
(119)
|
(113)
|
(116)
|
(103)
|
(86)
|
(86)
|
(64)
|
|
| Net Income (Common) |
(25)
N/A
|
(61)
-142%
|
(88)
-46%
|
(108)
-22%
|
(128)
-19%
|
(122)
+5%
|
(151)
-24%
|
(161)
-7%
|
(165)
-2%
|
(164)
+1%
|
(133)
+19%
|
(123)
+8%
|
(120)
+3%
|
(119)
+1%
|
(113)
+5%
|
(116)
-3%
|
(103)
+12%
|
(86)
+17%
|
(86)
-1%
|
(64)
+25%
|
|
| EPS (Diluted) |
-0.47
N/A
|
-1.14
-143%
|
-1.64
-44%
|
-1.97
-20%
|
-2.34
-19%
|
-2.2
+6%
|
-2.76
-25%
|
-2.88
-4%
|
-2.94
-2%
|
-2.9
+1%
|
-2.37
+18%
|
-2.15
+9%
|
-2.11
+2%
|
-2.04
+3%
|
-1.95
+4%
|
-1.95
N/A
|
-1.71
+12%
|
-1.41
+18%
|
-1.43
-1%
|
-1.07
+25%
|
|